Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) EPS (Basic): 2020-2025

Historic EPS (Basic) for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -$0.30.

  • Caribou Biosciences' EPS (Basic) rose 21.05% to -$0.30 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.70, marking a year-over-year decrease of 2.41%. This contributed to the annual value of -$1.65 for FY2024, which is 19.57% down from last year.
  • Caribou Biosciences' EPS (Basic) amounted to -$0.30 in Q3 2025, which was up 48.28% from -$0.58 recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' EPS (Basic) registered a high of -$0.12 during Q3 2023, and its lowest value of -$1.39 during Q1 2021.
  • Its 3-year average for EPS (Basic) is -$0.40, with a median of -$0.42 in 2024.
  • Data for Caribou Biosciences' EPS (Basic) shows a peak YoY increase of 81.55% (in 2021) and a maximum YoY decrease of 531.82% (in 2021) over the last 5 years.
  • Caribou Biosciences' EPS (Basic) (Quarterly) stood at -$0.31 in 2021, then plummeted by 45.16% to -$0.45 in 2022, then rose by 11.11% to -$0.40 in 2023, then rose by 2.50% to -$0.39 in 2024, then rose by 21.05% to -$0.30 in 2025.
  • Its EPS (Basic) was -$0.30 in Q3 2025, compared to -$0.58 in Q2 2025 and -$0.43 in Q1 2025.